SPOTLIGHT -
Ms Kuntz is the assistant managing editor of Psychiatric Times.
Celebrating Psychiatry: Conference Highlights Advances
Did you miss the Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
Mindfulness for Pediatric ADHD
Can mindfulness be an additional therapy to help treat ADHD in children?
Child and Adolescent Mental Health: A National Emergency
Three leading groups in child and adolescent mental health have declared a state of emergency for the nation’s youth.
“Never Silence Your Pain”: Life After a Suicide Attempt
One man shares his suicide survival story, and what he does to aid suicide prevention.
A Life and Death Measure: Eating Disorder Treatment
Nearly 80% of eating disorders go undetected. What screening tools can help identify them?
New Investigational Social Anxiety Disorder Drug Differentiates Mechanism of Action
PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.
The Challenges and Rewards of Working With Culturally Different Patients
Cultural differences between patients and physician are hard to avoid. How can you best work with diverse patients?
Treating Transgender Youth: The Danger of Gender Identity Conversion Therapy
Transgender youth are at increased risk for a number of psychiatric morbidities. Gender identity conversion therapy can make them worse.
Psychedelics: Psychiatry of the Future
Phase 3 results on MDMA-assisted therapy look promising for the treatment of PTSD. What other disorders can psychedelics help treat?
Chronic Adolescent THC Exposure: Mental Health Crisis?
Chronic adolescent exposure to THC and cannabis could lead to adverse mental health outcomes and impacted brain functioning.
Pioneering Psychopharmacology: Educator of the Year Award
Bringing science to the practice of psychiatry has been the personal goal of Sheldon H. Preskorn, MD—the Educator of the Year.
Hello, From the Other Side: Psychiatric Complications in a Future Postpandemic World
Psychiatric Times' Editor in Chief shared some insights and data on the psychiatric impacts of COVID-19, and what we might expect in the future.
Drug Update: Clozapine REMS Recertification
Modifications to the Clozapine Risk Evaluation and Mitigation Strategy go into effect November 15, 2021. Are you up to date?
Favorable Results for Bipolar Depression Treatment
Caplyta shows promise as a monotherapy for patients with bipolar I or bipolar II disorder experiencing a major depressive episode
Suicide: Myths, Media, and Difficult Discussions
The Chief Medical Officer for the American Foundation for Suicide Prevention sat down to talk with Psychiatric Times about a number of important topics in suicide.
Tourette’s or Mass Sociogenic Illness? You Decide
According to German researchers, YouTube and other online platforms could induce a “mass social media-induced illness.”
The AMA’s 7 Recommendations for Reducing the Opioid Crisis
The American Medical Association is urging policymakers to act now to prevent further opioid overdose deaths.
A Vaccine to Treat Opioid Disorders: First Participant Enrolled in Trial
A vaccine that prevents oxycodone from entering the brain? This might be the safe, long-lasting, cost-effective solution for opioid use disorders.
Afghanistan Veterans Struggling With Mental Health
A recent survey found 70% of Afghanistan veterans have struggled with their mental health since serving.
FDA Workshop Plans to Discuss Potential Mandatory Opioid Prescriber Education
The FDA is holding a workshop to discuss mandatory opioid prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Nasal Spray for Treatment of Migraine Approved by FDA
The first and only treatment to use proprietary precision olfactory delivery technology to deliver DHE to the upper nasal cavity just received FDA approval.
APA and Other Leading Physician Groups Oppose Texas Legislation That Interferes With Patient Reproductive Care
6 frontline physician groups expressed their concern about the Texas state law that bans abortions after 6 weeks of pregnancy.
First and Only Twice-Yearly Treatment for Schizophrenia Receives FDA Approval
The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.
Suicide: The Lesser-Known Hazard for Construction Workers
According to the CDC, construction workers commit suicide 4 times more than the general population. What can be done to stem this hazard?
Addressing Afghanistan: The American Psychiatric Association’s Statement
Mental health care for US service members, refugees, and Afghans will be crucial.
In the Wake of 9/11: Mental Health Statistics of First Responders
What toll does trauma take on police officers, firefighters, and EMT workers?
Study Shows Pandemic Resulted in Increases in Intimate Partner Aggression
First of its kind study found aggression in US couples saw a 6- to 8-fold increase during the pandemic.
Meeting the Needs of Correctional Health Care Clinicians: NCCHC Holds Educational Conference for First Time in 2 Years
The National Correctional Health Care Conference is back and ready to deliver the latest on correctional and public health.
Developing a Novel Psychedelic: Salvinorin A
A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.
First and Only Medicine Indicated to Treat Idiopathic Hypersomnia
This hypersomnia treatment just received an extended approval for cataplexy and excessive daytime sleepiness.